Guojian Pharmaceutical

Guojian Pharmaceutical, established in 2002, is one of the first innovative biopharmaceutical enterprises in China to focus on antibody drugs. It has grown into a pioneer in China's antibody drug industry with capabilities in independent research and development, industrialization, and commercialization. The company operates the National Engineering Research Center for Antibody Drugs and runs one of the largest antibody drug production bases among China's biopharmaceutical companies, with a total bioreactor capacity exceeding 40,000 liters. Focusing on innovative therapeutic antibody drugs as its main R&D direction, Guojian Pharmaceutical provides high-quality, safe, and effective clinical solutions for major disease treatment areas such as autoimmune diseases. Adhering to the corporate philosophy of "Cherishing life, focusing on survival, and creating a better life," Guojian Pharmaceutical is committed to becoming a company that benefits China and faces the world, contributing to human health. It fulfills its corporate mission of "Making innovative antibody drugs accessible" to continuously enhance people's sense of gain, happiness, and security, supporting the early realization of Healthy China.